Literature DB >> 2655224

Induction of intestinal graft-versus-host reactions across mutant major histocompatibility antigens by T lymphocyte subsets in mice.

A M Mowat1, J Sprent.   

Abstract

We have examined the ability of highly purified subsets of C57B1/6 L3T4+ and Lyt2+ cells to cause intestinal graft-versus-host reactions in H-2 mutant mice expressing isolated class I (bm1) or II (bm12) MHC mutations. Heavily irradiated B6xbm12)F1 mice given B6 L3T4+ T cells (anti-class II GVHR) developed an acute, lethal GVHR that was associated with intense jejunal crypt hyperplasia and an early rise in the density of intraepithelial lymphocytes. Irradiated (B6xbm1)F1 mice given B6 Lyt2+ T cells (anti-class I GVHR) showed a similar phase of crypt hyperplasia within the first 2 weeks, but this was less marked than for anti-class II GVHR and was not associated with an increase in IEL count. Only very minor gut pathology was observed when B6 Lyt2+ T cells were transferred to irradiated mice carrying the bm9 class I mutation, which is much weaker than the bm1 mutation and does not stimulate Lyt2+ helper T cells. The GVHR mediated by B6 L3T4+ and Lyt2+ T cells was H-2 class-specific, as no pathology was seen in bm12 recipients of Lyt2+ cells or in bm1 recipients of L3T4+ cells. B6 L3T4+ and Lyt2+ T cells both induced splenomegaly and intestinal GVHR in nonirradiated, 4-5-day-old neonatal (B6xbm12)F1 or (B6xbm1)F1 mice, respectively, a form of intestinal GVHR that does not require specific cytotoxic T lymphocytes. Again, Lyt2+ T cells were less efficient than L3T4+ T cells in the induction of GVHR. Thus, both class I and class II MHC-restricted T cells can mediate different forms of intestinal GVHR under appropriate circumstances, but class II MHC-restricted T cells may be more efficient.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2655224     DOI: 10.1097/00007890-198905000-00022

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  6 in total

Review 1.  Graft-versus-host disease of the intestine.

Authors:  G J Cox; G B McDonald
Journal:  Springer Semin Immunopathol       Date:  1990

2.  Characterization of target injury of murine acute graft-versus-host disease directed to multiple minor histocompatibility antigens elicited by either CD4+ or CD8+ effector cells.

Authors:  G F Murphy; D Whitaker; J Sprent; R Korngold
Journal:  Am J Pathol       Date:  1991-04       Impact factor: 4.307

3.  A role for IL-4 in immunologically mediated enteropathy.

Authors:  A M Mowat; M B Widmer
Journal:  Clin Exp Immunol       Date:  1995-01       Impact factor: 4.330

4.  A role for interleukin-1 alpha in immunologically mediated intestinal pathology.

Authors:  A M Mowat; A K Hutton; P Garside; M Steel
Journal:  Immunology       Date:  1993-09       Impact factor: 7.397

5.  Transfer of the inflammatory disease of HLA-B27 transgenic rats by bone marrow engraftment.

Authors:  M Breban; R E Hammer; J A Richardson; J D Taurog
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307

Review 6.  Treatment of graft-versus-host disease with naturally occurring T regulatory cells.

Authors:  Piotr Trzonkowski; Anna Dukat-Mazurek; Maria Bieniaszewska; Natalia Marek-Trzonkowska; Anita Dobyszuk; Jolanta Juścińska; Magdalena Dutka; Jolanta Myśliwska; Andrzej Hellmann
Journal:  BioDrugs       Date:  2013-12       Impact factor: 5.807

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.